GLUCORX TECHNOLOGIES LIMITEDActive

Company number SC575629Private limited companyIncorporated 2017

Key figures

−£11,169,468-11.4%
Net assets 2024/25
-15 m-10 m-5 m02019/202020/212021/222022/232023/242024/25

GLUCORX TECHNOLOGIES LIMITED does not disclose its turnover in its latest accounts; the profit for the year is as stated in the accounts.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
05 m10 m15 m2019/202020/212021/222022/232023/242024/25
Filed accounts2019/20–2024/25
2020/212021/222022/232023/242024/25
Profit for the year———-1,190,802-1,141,239
Cash at bank and in hand62,39174,51654,16746,77398,876
Total assets140,794153,779146,554144,856205,342
Total liabilities———10,188,83011,384,127
Net assets / total equity-6,381,426-8,212,236-8,837,427-10,028,229-11,169,468
Average number of employees212221230

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: GLUCORX TECHNOLOGIES LIMITED

Company

GLUCORX TECHNOLOGIES LIMITED is a private limited company registered with Companies House under company number SC575629. It was incorporated on 6 Sep 2017. Its status is active. The registered office is in Dingwall (IV15). Its nature of business (SIC 2007) is manufacture of medical and dental instruments and supplies (32500).

Accounts

The latest accounts in the database are for 2024/25 (period ending 31 Mar 2025); the company files small company accounts. Loss for the year was £1,141,239. Net assets were −£11,169,468, down 11.4% on the previous year. Cash at bank and in hand was £98,876. Total assets were £205,342 and total liabilities £11,384,127. The company had an average of 0 employees. Figures are available for 6 financial years (2019/20–2024/25).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 31 Dec 2026. The next confirmation statement is due by 19 Sep 2027.